{"SPADE_UN_15928": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15928", "Peptide Name": "Alyteserin-2a [G11k, N15K]", "Source": "Synthetic (Derived from Alyteserin-2a)", "Family": "", "Gene": "Not found", "Sequence": "ILGKLLSTAAKLLSKL", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (LC50=15 μM); MDA-MB-231 (LC50=20 μM); HepG2 (LC50=26 μM); HT-29 (LC50=28 μM)", "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=195 µM", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C72H131N17O18", "Mass": 1669.1, "PI": 10.3, "Net Charge": 3, "Hydrophobicity": 1.03, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent", "Pubmed ID": "22965637", "Reference": "Amino Acids. 2013 Feb;44(2)715-23.", "Author": "Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22965637"}], "Frequent Amino Acids": "LKA", "Absent Amino Acids": "CDEFHMNOPQRUVWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 8, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15928", "Similarity": 1.0, "Sequence": "ILGKLLSTAAKLLSKL"}, {"SPADE_ID": "SPADE_UN_15920", "Similarity": 0.9375, "Sequence": "ILGKLLSTAAKLLSNL"}, {"SPADE_ID": "SPADE_UN_15921", "Similarity": 0.9375, "Sequence": "ILGKLLSTAAKLLSNL"}]}}}